This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Van Steeg, H. Articles by Van Kreijl, C. F. Search for Related Content PubMed PubMed Citation Articles by Van Steeg, H. Articles by Van Kreijl, C. F. Social Bookmarking                   What's this?

DNA Repair—Deficient Xpa and Xpa/p53+/- Knock-Out Mice: Nature of the Models

National Institute of Public Health and the Environment (RIVM), Laboratory of Health Effects Research, H.van.Steeg@ rivm.nl

Annemieke De Vries

National Institute of Public Health and the Environment (RIVM), Laboratory of Health Effects Research

Conny TH. M. Van Oostrom

National Institute of Public Health and the Environment (RIVM), Laboratory of Health Effects Research

Jan Van Benthem

National Institute of Public Health and the Environment (RIVM), Laboratory of Health Effects Research

Rudolf B. Beems

Laboratory for Pathology and Immunobiology, P.O. Box 1, 3720 BA Bilthoven, The Netherlands

Coen F. Van Kreijl

National Institute of Public Health and the Environment (RIVM), Laboratory of Health Effects Research

Xeroderma pigmentosum (XP) is a rare autosomal recessive disease in which repair of ultraviolet (UV)-induced DNA damage is impaired or is totally absent due to mutations in genes controlling the DNA repair pathway known as nucleotide excision repair (NER). XP is characterized, in part, by extreme sensitivity of the skin to sunlight, and XP patients have a more than 1000-fold increased risk of developing cancer at sun-exposed areas of the skin. To study the role of NER in chemical-induced tumorigenesis in more detail, the authors developed Xpa^-/- homozygous knockout mice with a complete defect in NER (designated as Xpa mice or XPA model). Xpa mice develop skin tumors at high frequency when exposed to UV light, and as such, they mimic the phenotype of human XP. Moreover, the Xpa mice also appear to be susceptible to genotoxic carcinogens given orally. Based on these phenotypic characteristics, the Xpa mice were considered to be an attractive candidate mouse model for use in identifying human carcinogens. In an attempt to further increase both the sensitivity and specifi city of the XPA model in carcinogenicity testing, the authors crossed Xpa mice with mice having a heterozygous defect in the tumor suppressor gene p53. Xpa/p53^+/- double knockout mice develop tumors earlier and with higher incidences upon exposure to carcinogens as compared to their single knockout counterparts. Here the authors describe the development and features of the Xpa mouse and present some examples of the Xpa and Xpa/p53^+/- mouse models' sensitivity towards genotoxic carcinogens. It appeared that the Xpa/p53 ^+/- double knockout mouse model is favorable over both the Xpa and p53^+/- single knockout models in short-term carcinogenicity testing. In addition to the fact that the double knockout mice respond more robustly to carcinogens, they also appear to respond in a very discriminative way. All compounds identified thus far are true (human) carcinogens, and, therefore, the authors believe that the Xpa/p53^+/- mouse model is an excellent candidate for a future replacement of the chronic mouse bioassay, at least for certain classes of chemicals.

Key Words: Carcinogenicity testing • genotoxiccarcinogens • nucleotideexcisionrepair • p53 tumor suppressor gene • xerodermapigmentosum • XPA.

Toxicologic Pathology, Vol. 29, No. 1 suppl, 109-116 (2001)
DOI: 10.1080/019262301753178519


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P. C.E. van Kesteren, R. B. Beems, M. Luijten, J. Robinson, A. de Vries, and H. van Steeg DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance? Carcinogenesis, March 1, 2009; 30(3): 538 - 543. [Abstract] [Full Text] [PDF]

				P. A. McAnulty and M. Skydsgaard Diethylstilbestrol (DES): Carcinogenic Potential in Xpa-/-, Xpa-/-/p53+/-, and Wild-Type Mice During 9 Months' Dietary Exposure Toxicol Pathol, August 1, 2005; 33(5): 609 - 620. [Abstract] [Full Text] [PDF]

				B. A.R. Lina, R. A. Woutersen, J. P. Bruijntjes, J. Van Benthem, J. A.H. Van Den Berg, J. Monbaliu, B. J.J.M. Thoolen, R. B. Beems, and C. F. Van Kreijl Evaluation of the Xpa-Deficient Transgenic Mouse Model for Short-Term Carcinogenicity Testing: 9-Month Studies with Haloperidol, Reserpine, Phenacetin, and D-Mannitol Toxicol Pathol, February 1, 2004; 32(2): 192 - 201. [Abstract] [PDF]

				D. Jacobson-Kram, F. D. Sistare, and A. C. Jacobs Use of Transgenic Mice in Carcinogenicity Hazard Assessment Toxicol Pathol, January 1, 2004; 32(1_suppl): 49 - 52. [Abstract] [PDF]

				S. R. Payne and C. J. Kemp p27 Kip1 (Cdkn1b)-Deficient Mice Are Susceptible to Chemical Carcinogenesis and May Be a Useful Model for Carcinogen Screening Toxicol Pathol, June 1, 2003; 31(4): 355 - 363. [Abstract] [PDF]

				E. M. Hoogervorst, A. de Vries, R. B. Beems, C. Th.M. van Oostrom, P. W. Wester, J. G. Vos, W. Bruins, M. Roodbergen, F. R. Cassee, J. Vijg, et al. Combined oral benzo[a]pyrene and inhalatory ozone exposure have no effect on lung tumor development in DNA repair-deficient Xpa mice Carcinogenesis, March 1, 2003; 24(3): 613 - 619. [Abstract] [Full Text] [PDF]